Literature DB >> 16625007

The challenge of subgroup analyses--reporting without distorting.

Stephen W Lagakos1.   

Abstract

Mesh：

Year:  2006        PMID： 16625007     DOI： 10.1056/NEJMp068070

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  116 in total

1.  Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.

Authors:  Elena Losina; James Wright; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

2.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

4.  Interaction trees with censored survival data.

Authors:  Xiaogang Su; Tianni Zhou; Xin Yan; Juanjuan Fan; Song Yang
Journal:  Int J Biostat       Date:  2008-01-28       Impact factor: 0.968

5.  Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

Authors:  Kevin E Chan; Timothy A Pflederer; David J R Steele; Michael P Lilly; T Alp Ikizler; Frank W Maddux; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

6.  Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.

Authors:  Henk M Lokhorst; Bronno van der Holt; Jan J Cornelissen; Marie José Kersten; Marinus van Oers; Reinier Raymakers; Monique C Minnema; Sonja Zweegman; Gerard Bos; Nicolaas Schaap; Shulamiet Wittebol; Okke de Weerdt; Rianne Ammerlaan; Pieter Sonneveld
Journal:  Haematologica       Date:  2015-09-04       Impact factor: 9.941

Review 7.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Authors:  Kanwal Pratap Singh Raghav; Sminil Mahajan; James C Yao; Brian P Hobbs; Donald A Berry; Rebecca D Pentz; Alda Tam; Waun K Hong; Lee M Ellis; James Abbruzzese; Michael J Overman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

8.  Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

Authors:  L Altstein; G Li
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

9.  Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis.

Authors:  Anna Mathew; Michael Eliasziw; P J Devereaux; Jose G Merino; Henry J M Barnett; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 10.121

10.  Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.

Authors:  Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2006-11-01       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.